SCHEMBL2745809

SCHEMBL2745809

NC(=O)OCCCOC(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.52
TSHR P16473 3/20 0.52
CHRM2 P08172 2/20 0.52
CHRM4 P08173 2/20 0.52
CHRM5 P08912 2/20 0.52
CHRM1 P11229 2/20 0.52
CHRM3 P20309 2/20 0.52
CHRNB2 P17787 2/20 0.52
CHRNA4 P43681 2/20 0.52
HTR1A P08908 1/20 0.52
CYP2C19 P33261 1/20 0.52
CHRNA7 P36544 1/20 0.52
ALOX15 P16050 1/20 0.50
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ATM Q13315 1/20 0.35
SERPINE1 P05121 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL10897945 0.97 LMNA (0.50) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL2746597 0.93 TSHR (0.52) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL31296577 0.90 TSHR (0.50) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL5721434 0.90 TSHR (0.50) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL2139712 0.90 TSHR (0.50) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL2136691 0.90 TSHR (0.50) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL2059697 0.90 TSHR (0.50) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL2746089 0.90 TSHR (0.50) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL5721317 0.90 TSHR (0.50) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL2136844 0.90 TSHR (0.50) LMNATSHRCHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2841496-B1 RUBBER COMPOSITIONS ALLNEX GERMANY GMBH (DE) 2022-10-26 EP claimed
CN-110498751-A A kind of imprinted templates molecule and its preparation method and application UNIV NANJING MEDICAL 2019-11-26 CN claimed
US-8476428-B2 Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-07-02 US claimed
US-20120202993-A1 METHOD OF PREPARING CYCLIC CARBONATES, CYCLIC CARBAMATES, CYCLIC UREAS, CYCLIC THIOCARBONATES, CYCLIC THIOCARBAMATES, AND CYCLIC DITHIOCARBONATES INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-08-09 US claimed
US-20100280242-A1 Method of Preparing Cyclic Carbonates, Cyclic Carbamates, Cyclic Ureas, Cyclic Thiocarbonates, Cyclic Thiocarbamates, and Cyclic Dithiocarbonates INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-11-04 US claimed
CN-118829423-A Compositions for delivery of payload molecules to airway epithelium 摩登纳特斯有限公司 2024-10-22 CN disclosed
CN-117586235-A Chimeric molecules for enhancing mitochondrial autophagy and uses thereof 广东省人民医院 2024-02-23 CN disclosed
CN-116348147-A Compositions for delivery of payload molecules to airway epithelium 摩登纳特斯有限公司 2023-06-27 CN disclosed
CN-114230950-B Semiconductor equipment sealing element and preparation method thereof 上海芯密科技有限公司 2023-04-14 CN disclosed
EP-3620308-B1 PNEUMATIC TIRE GOODYEAR TIRE & RUBBER (US) 2022-12-21 EP disclosed
CN-110498751-A A kind of imprinted templates molecule and its preparation method and application UNIV NANJING MEDICAL 2019-11-26 CN disclosed
US-8754208-B2 Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-06-17 US disclosed
US-20130237701-A1 METHOD OF PREPARING CYCLIC CARBONATES, CYCLIC CARBAMATES, CYCLIC UREAS, CYCLIC THIOCARBONATES, CYCLIC THIOCARBAMATES, AND CYCLIC DITHIOCARBONATES INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-09-12 US disclosed
US-8476428-B2 Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-07-02 US disclosed
WO-2013020079-A2 CONJUGATES OF AN IL-11 MOIETY AND A POLYMER NEKTAR THERAPEUTICS (US) 2013-02-07 WO disclosed
US-20120202993-A1 METHOD OF PREPARING CYCLIC CARBONATES, CYCLIC CARBAMATES, CYCLIC UREAS, CYCLIC THIOCARBONATES, CYCLIC THIOCARBAMATES, AND CYCLIC DITHIOCARBONATES INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-08-09 US disclosed
US-8178700-B2 Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-05-15 US disclosed
US-20100280242-A1 Method of Preparing Cyclic Carbonates, Cyclic Carbamates, Cyclic Ureas, Cyclic Thiocarbonates, Cyclic Thiocarbamates, and Cyclic Dithiocarbonates INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202993-A1 METHOD OF PREPARING CYCLIC CARBONATES, CYCLIC CARBAMATES, CYCLIC UREAS, CYCLIC THIOCARBONATES, CYCLIC THIOCARBAMATES, AND CYCLIC DITHIOCARBONATES CPS1, TST, CTH LMNA 4184/4885TSHR 232/4885CHRM2 2059/4885
US-20130237701-A1 METHOD OF PREPARING CYCLIC CARBONATES, CYCLIC CARBAMATES, CYCLIC UREAS, CYCLIC THIOCARBONATES, CYCLIC THIOCARBAMATES, AND CYCLIC DITHIOCARBONATES CPS1, TST, CTH LMNA 4184/4885TSHR 232/4885CHRM2 2059/4885
US-20100280242-A1 Method of Preparing Cyclic Carbonates, Cyclic Carbamates, Cyclic Ureas, Cyclic Thiocarbonates, Cyclic Thiocarbamates, and Cyclic Dithiocarbonates CPS1, TST, CTH LMNA 4184/4885TSHR 232/4885CHRM2 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.